The effects of 2-methoxyoestrogen sulphamates on the in vitro and in vivo proliferation of breast cancer cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 94, Issue 1-3 SPEC. ISS., 2005, Pages 219-227

  Utsumi, T ^a,c   Leese, M P ^b   Chander, S K ^a   Gaukroger, K ^b   Purohit, A ^a   Newman, S P ^a   Potter, B V L ^b   Reed, M J ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF BATH   (United Kingdom)

^c FUJITA HEALTH UNIVERSITY   (Japan)

Author keywords

Breast cancer; Methoxyoestrogen sulphamate; Oestrogens; Oestrone sulphate; Steroid sulphatase

Indexed keywords

2 METHOXYESTRADIOL 17BETA CYANOMETHYL 3 O SULFAMATE; 2 METHOXYESTRADIOL BIS(SULFAMATE); ESTRADIOL DERIVATIVE; STERYL SULFATASE; UNCLASSIFIED DRUG;

ARTICLE; BIOASSAY; BREAST CARCINOMA; CANCER CELL; CANCER CELL CULTURE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; DRUG EFFECT; ENZYME ACTIVITY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IC 50; IN VIVO STUDY; INTRACELLULAR KILLING; TUMOR GROWTH;

MINK CELL FOCUS-FORMING VIRUS; MUS MUSCULUS;

EID: 18144409797     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2005.01.022     Document Type: Article

References (31)

1. M.J. Reed, J.D. Hutton, P.M. Baxendale, V.H.T. James, H.S. Jacobs, and R.P. Fisher The conversion of androstenedione to oestrone and production of oestrone in women with endometrial cancer J. Steroid Biochem. 11 1979 905 911
2. V.H.T. James, J.M. McNeill, L.C. Lai, C.J. Newton, M.W. Ghilchik, and M.J. Reed Aromatase activity in normal breast and breast tumour tissue: in vivo and in vitro studies Steroids 50 1987 269 279
3. M.J. Reed, A.M. Owen, L.C. Lai, N.G. Coldham, M.W. Ghilchik, N.A. Shaikh, and V.H.T. James In situ oestrone synthesis in normal breast and breast tumour tissue: effect of treatment with 4-hydroxyandrostenedione Int. J. Cancer 44 1989 233 237
4. W.R. Miller, and J.M. Dixon Local endocrine effects of aromatase inhibitors within the breast J. Steroid Biochem. Mol. Biol. 79 2001 93 102
5. A. Purohit, and M.J. Reed Regulation of estrogen synthesis in postmenopausal women Steroids 67 2002 979 983
6. L.W.L. Woo, A. Purohit, M.J. Reed, and B.V.L. Potter Active site-directed inhibition of estrone sulfatase by non steroidal Coumarin sulfamates J. Med. Chem. 39 1996 1349 1351
7. A. Purohit, L.W.L. Woo, B.V.L. Potter, and M.J. Reed In vivo inhibition of estrone sulfatase activity and growth of nitrosomethylurea-induced mammary tumors by 667 COUMATE Cancer Res. 60 2000 3394 3396
8. T. Utsumi, N. Yoshimura, S. Takeuchi, J. Ando, M. Maruta, K. Maeda, and N. Harada Steroid sulfatase expression is an independent predictor of recurrence in human breast cancer Cancer Res. 59 1999 377 381
9. N. Yoshimura, N. Harada, I. Bukholm, R. Karesen, A.-L. Borresen-Dale, and V.N. Kristensen Intratumoral mRNA expression and genes from the oestradiol metabolic pathway and clinical and histopathological parameters of breast cancer Breast Cancer Res. 6 2004 R46 R55
10. H.L. Bradlow, N.T. Telang, D.W. Sepkovic, and M.P. Osborne 2-Hydroxyestrone the 'good' estrogen J. Endocrinol. 150 1996 S259 S265
11. G.E. Swaneck, and J. Fishman Covalent binding of endogenous 16α-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intra-nuclear location Proc. Natl. Acad. Sci. U.S.A. 85 1988 7831 7835
12. B.T. Zhu, and A.H. Conney Is 2-methoxyestradiol an endogenous estrogen metabolite that inhibits mammary carcinogenesis? Cancer Res. 58 1998 2269 2277
13. J. Seegers, M-L. Aveling, C.H. Van Aswegen, M. Cross, F. Koch, and W.S. Joubert The cytotoxic effects of estradiol-17β, catecholestradiols and methoxyestradiols on dividing MCF-7 and HeLa cells J. Steroid Biochem. 32 1989 797 809
14. R.J. D'Amato, C. Lin, E. Flynn, J. Folkman, and E. Hamel 2-Methoxyestradiol, an endogenous mammalian metabolite, inhibits tubulin polymerization by interacting at the colchicine site Proc. Natl. Acad. Sci. U.S.A. 91 1994 3964 3968
15. W.S. Pribluda, E.R. Gubish, T.M. Lu Vallee, A. Treston, G.M. Swartz, and S. Green Methoxyestradiol: an endogenous antiangiogenic and antiproliferative drug candidate Cancer Met. Rev. 19 2000 173 179
16. T. Fotsis, Y. Zhang, M.S. Pepper, H. Adlercreutz, R. Montesano, P.P. Nawroth, and L. Schweigerer The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth Nature 368 1997 237 239
17. N. Klauber, S. Parangi, E. Flynn, E. Hamel, and R.J. D'Amato Inhibition of angiogenesis and breast cancer in mice by the microtuble inhibitors 2-methoxyestradiol and taxol Cancer Res. 57 1997 81 86
18. N.J. Lakhani, M.A. Sarkar, J. Venitz, and W.D. Figg 2-Methoxyestradiol, a promising anticancer agent Pharmacotherapy 23 2003 165 172
19. R.W. Bruggemeier, A.S. Bhat, C.J. Lovely, H.D. Coughenour, F. Yusuf, and W.G. Burak 2-Methoxymethylestradiol: a new 2-methoxyestrogen analog that exhibits antiproliferative activity and alters tubulin dynamics J. Steroid Biochem. Mol. Biol. 78 2001 145 156
20. T.L. Tinley, R.M. Leal, D.A. Randall-Hlubek, J.W. Cessac, L.R. Wilkens, P.N. Roa, and S.L. Mooberry Novel 2-methoxyestradiol analogues with antitumor activity Cancer Res. 63 2003 1538 1549
21. A. Purohit, K.A. Vernon, A.E. Wagenaar Hummelinck, L.W.L. Woo, H.A.M. Hejaz, B.V.L. Potter, and M.J. Reed The development of A-ring modified analogues of oestrone-3-O-sulphamate as potent steroid sulphatase inhibitors with reduced oestrogenicity J. Steroid Biochem. Mol. Biol. 64 1998 269 275
22. A. Purohit, H.A.M. Hejaz, L. Walden, B.V.L. Potter, and M.J. Reed The effect of 2-methoxyestrone sulfamate on the growth of breast cancer cells and induced mammary tumors Int. J. Cancer 85 2000 584 589
23. L. MacCarthy-Morrogh, P.A. Townsend, A. Purohit, H.A.M. Hejaz, B.V.L. Potter, M.J. reed, and G. Packham Differential effects of estrone and estrone-3-O-sulfamate derivatives on mitotic arrest, apoptosis and microtuble assembly in human breast cancer cells Cancer Res. 60 2000 5441 5450
24. S.P. Newman, M.P. Leese, A. Purohit, D.R.C. James, C.E. Rennie, B.V.L. Potter, and M.J. Reed Inhibition of in vitro angiogenesis by 2-methoxy and 2-ethyl estrogen sulfamates Int. J. Cancer 109 2004 533 540
25. L.J. Duncan, A. Purohit, N.M. Howarth, B.V.L. Potter, and M.J. Reed Inhibition of estrone sulfatase activity by estrone-3-methylthiophosphonate: a potential therapeutic agent in breast cancer Cancer Res. 53 1993 298 303
26. A. Purohit, G.J. Williams, N.M. Howarth, B.V.L. Potter, and M.J. Reed Inactivation of steroid sulfatase by an active site-directed inhibitor, estrone-3-O-sulfamate Biochemistry 34 1995 11508 11514
27. C.R. Ireson, S.K. Chander, A. Purohit, S. Perera, S.P. Newman, D. Parish, A.C. Smith, B.V.L. Potter, and M.J. Reed Pharmacokinetics and efficacy of 2-methoxyoestradiol and 2-methoxyoestradiol-bis-sulphamate in vivo in rodents Brit. J. Cancer 90 2004 932 937
28. M.P. Leese, H.A.M. Hejaz, M.F. Mahon, S.P. Newman, A. Purohit, M.J. Reed, B.V.L. Potter, A-ring substituted oestrogen-3-O-sulfamates: potent multi-targeted anti-cancer agents. J. Med. Chem., submitted for publication.
29. N. Vicker, Y.T. Ho, J. Robinson, L.W.L. Woo, A. Purohit, M.J. Reed, and B.V.L. Potter Docking studies of sulphamate inhibitors of estrone sulphatase in human carbonic anhydrase II Bioorg. Med. Chem. Lett. 13 2003 863 865
30. Y.T. Ho, A. Purohit, N. Vicker, S.P. Newman, J.J. Robinson, M.P. Leese, D. Ganeshapillai, L.W.L. Woo, B.V.L. Potter, and M.J. Reed Inhibition of carbonic anhydrase II by steroidal and non-steroidal sulphamates Biochem. Biophys. Res. Comm. 305 2003 909 914
31. A. Purohit, G.J. Williams, C.J. Roberts, B.V.L. Potter, and M.J. Reed In vivo inhibition of oestrone sulphatase and dehydroepiandrosterone sulphatase by oestrone-3-O-sulphamate Int. J. Cancer 63 1995 106 111